ACHIEVE LIFE SCIENCES, INC. cotiza a 7.00 USD y tiene una capitalización bursátil de $722M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces th…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.19 | $-0.28 |
| Estimado | $-0.19 | $-0.16 | $-0.30 | $-0.28 |
| Sorpresa | — | — | +36.7% | +0.0% |
| Métrica | ACHV | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -254.0% | -40.4% | -213.6% |
| ROA | -130.8% | -32.0% | -98.8% |
| Current Ratio | 4.39 | 2.84 | +1.55 |
| Debt / Equity | — | 0.28 | — |